The genes for major psychosis: Aberrant sequence or regulation?

Neuropsychopharmacology

Volumn 23, Issue 1, 2000, Pages 1-12

  Petronis, Arturas ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Bipolar affective disorder; Chromatin conformation; Chromosome 18; DNA methylation; Dopamine D3 receptor gene; Epigenetics; Epimutation; Genetic association; Genetic linkage; Genomic imprinting; Parent of origin effect; Schizophrenia; Serotonin 2A receptor gene

Indexed keywords

DNA; DOPAMINE 3 RECEPTOR; MESSENGER RNA; NEUROLEPTIC AGENT; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

ALLELE; CHROMATIN STRUCTURE; CHROMOSOME 18; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOME IMPRINTING; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA;

EID: 0034125860     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00127-5     Document Type: Article

References (99)

1. Adami G., Babiss L.E. DNA template effect on RNA splicing. two copies of the same gene in the same nucleus are processed differently Embo J. 10:1991;3457-3465.
2. Arranz M., Collier D., Sodhi M., Ball D., Roberts G., Price J., Sham P., Kerwin R. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet. 346:1995;281-282.
3. Arranz M.J., Munro J., Sham P., Kirov G., Murray R.M., Collier D.A., Kerwin R.W. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr Res. 32:1998;93-99.
4. Asherson P., Mant R., Holmans P., Williams J., Cardno A., Murphy K., Jones L., Collier D., McGuffin P., Owen M.J. Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry. 1:1996;125-132.
5. Barlow D.P.A. Gametic imprinting in mammals. Science. 270:1995;1610-1613.
6. Bender C.M., Zingg J.M., Jones P.A. DNA methylation as a target for drug design. Pharm Res. 15:1998;175-187.
7. Bennett S.T., Wilson A.J., Esposito L., Bouzekri N., Undlien D.E., Cucca F., Nistico L., Buzzetti R., Bosi E., Pociot F., Nerup J., Cambon-Thomsen A., Pugliese A., Shield J.P., McKinney P.A., Bain S.C., Polychronakos C., Todd J.A. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB Group. Nature Genet. 17:1997;350-352.
8. Bestor T.H., Chandler V.L., Feinberg A.P. Epigenetic effects in eukaryotic gene expression. Develop Genet. 15:1994;458-462.
9. Bunzel R., Blumcke I., Cichon S., Normann S., Schramm J., Propping P., Nothen M.M. Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain. Brain Res Mol Brain Res. 59:1998;90-92.
10. Burnet P.W., Eastwood S.L., Harrison P.J. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacol. 15:1996;442-455.
11. Camus A.M., Bereziat J.C., Shuker D.E., Hietanen E., Wild C.P., Montesano R., Bartsch H. Effects of a high fat diet on liver DNA methylation in rats exposed to N-nitrosodimethylamine. Carcinogenesis. 11:1990;2093-2095.
12. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics. 22:1999;231-238.
13. Clifford C.P., Nunez D.J. 5HT2A receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1830.
14. Cockett N.E., Jackson S.P., Shay T.L., Farnir F., Berghmans S., Snowder G.D., Nielsen D.M., Georges M. Polar overdominance at the ovine callipyge locus. Science. 273:1996;236-238.
15. Coffee B., Zhang F., Warren S.T., Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet. 22:1999;98-101.
16. Collins J.S., Go R.C. Disease classification and transmission effects on linkage analyses in the NIMH1 bipolar disorder pedigrees. Genet Epidemiol. 14:1997;587-592.
17. Crocq M.A., Mant R., Asherson P., Williams J., Hode Y., Mayerova A., Collier D., Lannfelt L., Sokoloff P., Schwartz J.C. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet. 29:1992;858-860.
18. Crow T.J. 5HT2A receptor, T102C polymorphism, and schizophrenia. Lancet. 347:1996;1832.
19. Detera-Wadleigh S.D., Badner J.A., Berrettini W.H., Yoshikawa T., Goldin L.R., Turner G., Rollins D.Y., Moses T., Sanders A.R., Karkera J.D., Esterling L.E., Zeng J., Ferraro T.N., Guroff J.J., Kazuba D., Maxwell M.E., Nurnberger J.I. Jr., Gershon E.S. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA. 96:1999;5604-5609.
20. Donald J.A., Salmon J.A., Adams L.J., Littlejohn T., Maher A., Mitchell P.B., Schofield P.R. Parental sex effects in bipolar affective disorder pedigrees. Genet Epidemiol. 14:1997;611-616.
21. Dubertret C., Gorwood P., Ades J., Feingold J., Schwartz J.C., Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia. ethnic heterogeneity and significant association in Caucasians Am J Med Genet. 81:1998;318-322.
22. Erdmann J., Shimron-Abarbanell D., Rietschel M., Albus M., Maier W., Korner J., Bondy B., Chen K., Shih J.C., Knapp M., Propping P., Nothen M.M. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene. Identification of two naturally occurring receptor variants and association analysis in schizophrenia Hum Genet. 97:1996;614-619.
23. Falls J.G., Pulford D.J., Wylie A.A., Jirtle R.L. Genomic imprinting. implications for human disease Am J Pathol. 154:1999;635-647.
24. Fletcher T.M., Hansen J.C. The nucleosomal array. structure/function relationships Crit Rev Eukaryot Gene Expr. 6:1996;149-188.
25. Frommer M., McDonald L.E., Millar D.S., Collis C.M., Watt F., Grigg G.W., Molloy P.L., Paul C.L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA. 89:1992;827-831.
26. Furlong R.A., Ho L., Walsh C., Rubinsztein J.S., Jain S., Paykel E.S., Easton D.F., Rubinsztein D.C. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet. 81:1998;58-63.
27. Gershon E.S., Badner J.A., Detera-Wadleigh S.D., Ferraro T.N., Berrettini W.H. Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar illness pedigrees. Am J Med Genet. 67:1996;202-207.
28. Greenwood C.M., Bull S.B. Incorporation of covariates into genome scanning using sib-pair analysis in bipolar affective disorder. Genet Epidemiol. 14:1997;635-640.
29. Griffon N., Crocq M.A., Pilon C., Martres M.P., Mayerova A., Uyanik G., Burgert E., Duval F., Macher J.P., Javoy-Agid F., Tamminga C.A., Schwartz J.C., Sokoloff P. Dopamine D3 receptor gene. organization, transcript variants, and polymorphism associated with schizophrenia Am J Med Genet. 67:1996;63-70.
30. Grigoroiu-Serbanescu M., Martinez M., Nothen M.M., Propping P., Milea S., Mihailescu R., Marinescu E. Patterns of parental transmission and familial aggregation models in bipolar affective disorder. Am J Med Genet. 81:1998;397-404.
31. Hawi Z., Myakishev M.V., Straub R.E., O'Neill A., Kendler K.S., Walsh D., Gill M. No association or linkage between the 5-HT2A T102C polymorphism and schizophrenia in Irish families. Am J Med Genet. 74:1997;370-373.
32. Hayashizaki Y., Hirotsune S., Okazaki Y., Hatada I., Shibata H., Kawai J., Hirose K., Watanabe S., Fushiki S., Wada S., Su- gimoto T., Kobayakawa K., Kawara T., Katsuki M., Shibuya T., Mukai T. Restriction landmark genomic scanning method and its various applications. Electrophoresis. 14:1993;251-258.
33. Hayward B.E., Moran V., Strain L., Bonthron D.T. Bidirectional imprinting of a single gene. GNAS1 encodes maternally, paternally, and biallelically derived proteins Proc Natl Acad Sci USA. 95:1998;5475-5480.
34. He L., Li T., Melville C., Liu S., Feng G.Y., Gu N.F., Fox H., Shaw D., Breen G., Liu X., Sham P., Brown J., Collier D., St Clair D. 102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. Am J Med Genet. 88:1999;95-98.
35. Henikoff S., Matzke M.A. Exploring and explaining epigenetic effects. Trends Genet. 13:1997;293-295.
36. Hollick J.B., Chandler V.L. Epigenetic allelic states of a maize transcriptional regulatory locus exhibit overdominant gene action. Genetics. 150:1998;891-897.
37. Holliday R. DNA methylation in eukaryotes. 20 years on Russo V.E.A., Martienssen R.A., Riggs A.D. Epigenetic Mechanisms of Gene Regulation. 1996;5-27 New York, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
38. Hornykiewicz O. Brain catecholamines in schizophrenia - A good case for noradrenaline. Nature. 299:1982;484-486.
39. Inayama Y., Yoneda H., Sakai T., Ishida T., Nonomura Y., Kono Y., Takahata R., Koh J., Sakai J., Takai A., Inada Y., Asaba H. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet. 67:1996;103-105.
40. Jantzen K., Fritton H.P., Igo-Kemenes T., Espel E., Janich S., Cato A.C., Mugele K., Beato M. Partial overlapping of binding sequences for steroid hormone receptors and DNase I hypersensitive sites in the rabbit uteroglobin gene region. Nucleic Acids Res. 15:1987;4535-4552.
41. Jinno Y., Yun K., Nishiwaki K., Kubota T., Ogawa O., Reeve A.E., Niikawa N. Mosaic and polymorphic imprinting of the WT1 gene in humans. Nat Genet. 6:1994;305-309.
42. Johnstone E.C., Crow T.J., Frith C.D., Carney M.W., Price J.S. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet. 1:1978;848-851.
43. Joober R., Benkelfat C., Brisbois K., Toulouse A., Turecki G., Lal S., Bloom D., Labelle A., Lalonde P., Fortin D., Alda M., Palmour R., Rouleau G.A. T102C polymorphism in the 5HT2A gene and schizophrenia. relation to phenotype and drug response variability J Psychiatry Neurosci. 24:1999;141-146.
44. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 19:1998;187-191.
45. Joyce J.A., Schofield P.N. Genomic imprinting and cancer. Mol Pathol. 51:1998;185-190.
46. Kato M.V., Shimizu T., Nagayoshi M., Kaneko A., Sasaki M.S., Ikawa Y. Genomic imprinting of the human serotonin-receptor (HTR2) gene involved in development of retinoblastoma. Am J Hum Genet. 59:1996;1084-1090.
47. Kato M.V., Ikawa Y., Hayashizaki Y., Shibata H. Paternal imprinting of mouse serotonin receptor 2A gene Htr2 in embryonic eye. a conserved imprinting regulation on the RB/Rb locus Genomics. 47:1998;146-148.
48. Kato T., Winokur G., Coryell W., Keller M.B., Endicott J., Rice J. Parent-of-origin effect in transmission of bipolar disorder. Am J Med Genet. 67:1996;546-550.
49. Kawai J., Hirotsune S., Hirose K., Fushiki S., Watanabe S., Hayashizaki Y. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Res. 21:1993;5604-5608.
50. Kidd K.K. Associations of disease with genetic markers. Deja vu all over again Am J Med Genet. 48:1993;71-73.
51. Kouzmenko A.P., Hayes W.L., Pereira A.M., Dean B., Burnet P.W., Harrison P.J. 5-HT2A receptor polymorphism and steady state receptor expression in schizophrenia. Lancet. 349:1997;1815.
52. Krawczak M., Ball E.V., Cooper D.N. Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am J Hum Genet. 63:1998;474-488.
53. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 274:1996;1527-1531.
54. Lewis R., Kapur S., Jones C., DaSilva J., Brown G.M., Wilson A.A., Houle S., Zipursky R.B. Serotonin 5-HT2 receptors in schizophrenia. A PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects Am J Psychiatry. 156:1999;72-78.
55. Lin J.P., Bale S.J. Parental transmission and D18S37 allele sharing in bipolar affective disorder. Genet Epidemiol. 14:1997;665-668.
56. Lopez A.J. Alternative splicing of pre-mRNA. Developmental consequences and mechanisms of regulation Annu Rev Genet. 32:1998;279-305.
57. Lundstrom K., Turpin M.P. Proposed schizophrenia-related gene polymorphism. Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system Biochem Biophys Res Commun. 225:1996;1068-1072.
58. McMahon F.J., Stine O.C., Meyers D.A., Simpson S.G., DePaulo J.R. Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet. 56:1995;1277-1286.
59. McMahon F.J., Hopkins P.J., Xu J., McInnis M.G., Shaw S., Cardon L., Simpson S.G., MacKinnon D.F., Stine O.C., Sherrington R., Meyers D.A., DePaulo J.R. Linkage of bipolar affective disorder to chromosome 18 markers in a new pedigree series. Am J Hum Genet. 61:1997;1397-1404.
60. Meador-Woodruff J.H., Haroutunian V., Powchik P., Davidson M., Davis K.L., Watson S.J. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry. 54:1997;1089-1095.
61. Moen P.T. Jr., Smith K.P., Lawrence J.B. Compartmentalization of specific pre-mRNA metabolism. an emerging view Hum Mol Genet. 4(Spec No):1995;1779-1789.
62. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 393:1998;386-389.
63. Nimchinsky E.A., Hof P.R., Janssen W.G.M., Morrison J.H., Schmauss C. Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem. 272:1997;29229-29237.
64. Nöthen M.M., Cichon S., Rohleder H., Hemmer S., Franzek E., Fritze J., Albus M., Borrmann-Hassenbach M., Kreiner R., Weigelt B., Minges J., Lichtermann D., Maier W., Craddock N., Fimmers R., Holler T., Baur M.P., Rietschel M., Propping P. Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Mol Psychiatry. 4:1999;76-84.
65. O'Donovan M.C., Owen M.J. Candidate-gene association studies of schizophrenia. Am J Hum Genet. 65:1999;587-592.
66. Ohlsson R., Tycko B., Sapienza C. Monoallelic expression. 'There can only be one' Trends Genet. 14:1998;435-438.
67. Paterson A. All alleles are equal, but some alleles are more equal than others. Molec Psychiat. 3:1998;212.
68. Petronis A. The regulation of D2 dopamine receptor expression. epigenetic factors should not be forgotten Molec Psychiat. 4(3):1999;212-213.
69. Petronis A., Paterson A.D., Kennedy J.L. Schizophrenia. An epigenetic puzzle? Schizophr Bull. 25:1999;639-655.
70. Petronis A, Vincent JB, Surh LC, Ashizawa T, Kennedy JL (in press): Polyglutamine-containing proteins in schizophrenia: an effect of lymphoblastoid cells? Molec Psychiat.
71. Popendikyte V., Laurinavicius A., Paterson A.D., Macciardi F., Kennedy J.L., Petronis A. DNA methylation at the putative promoter region of the human dopamine D2 receptor gene. NeuroReport. 10:1999;1249-1255.
72. Rice J. Genetic analysis of bipolar disorder. summary of GAW10 Genet Epidemiol. 14:1997;549-561.
73. Ridley R.M., Frith C.D., Crow T.J., Conneally P.M. Anticipation in Huntington's disease is inherited through the male line but may originate in the female. J Med Genet. 25:1988;589-595.
74. Riggs A.D., Porter T.N. Overview of epigenetic mechanims. Epigenetic mechanisms of gene regulation. 1996;29-45 Martienssen RA, Riggs AD (eds), Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, In Russo VEA.
75. Saluz H.P., Jiricny J., Jost J.P. Genomic sequencing reveals a positive correlation between the kinetics of strand-specific DNA demethylation of the overlapping estradiol/glucocorticoid-receptor binding sites and the rate of avian vitellogenin mRNA synthesis. Proc Natl Acad Sci USA. 83:1986;7167-7171.
76. Schmauss C., Haroutunian V., Davis K.L., Davidson M. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc Natl Acad Sci USA. 90:1993;8942-8946.
77. Schmauss C. Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia. J Neurosci. 16:1996;7902-7909.
78. Sharpe D. Of apples and oranges, file drawers and garbage. Why validity issues in meta-analysis will not go away Clin Psychol Rev. 17:1997;881-901.
79. Shemer R., Razin A. Establishment of imprinted methylation patterns during development. Russo V.E.A., Martienssen R.A., Riggs A.D. Epigenetic Mechanisms of Gene Regulation. 1996;215-229 New York, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
80. Smeraldi E., Zanardi R., Benedetti F., Di Bella D., Perez J., Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Molec Psychiat. 3:1998;508-511.
81. Solter D. Imprinting. Int J Dev Biol. 42(7 Spec No):1998;951-954.
82. Spurlock G., Heils A., Holmans P., Williams J., D'Souza U.M., Cardno A., Murphy K.C., Jones L., Buckland P.R., McGuffin P., Lesch K.P., Owen M.J. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Molec Psychiat. 3:1998;42-49. a.
83. Spurlock G., Williams J., McGuffin P., Aschauer H.N., Lenzinger E., Fuchs K., Sieghart W.C., Meszaros K., Fathi N., Laurent C., Mallet J., Macciardi F., Pedrini S., Gill M., Hawi Z., Gibson S., Jazin E.E., Yang H.T., Adolfsson R., Pato C.N., Dourado A.M., Owen M.J. European Multicentre Association Study of Schizophrenia. A study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms Am J Med Genet. 81:1998;24-28. b.
84. Stine O.C., Xu J., Koskela R., McMahon F.J., Gschwend M., Friddle C., Clark C.D., McInnis M.G., Simpson S.G., Breschel T.S., Vishio E., Riskin K., Feilotter H., Chen E., Shen S., Folstein S., Meyers D.A., Botstein D., Marr T.G., DePaulo R.J. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet. 57:1995;1384-1394.
85. Szyf M. The DNA methylation machinery as a target for anticancer therapy. Pharmacol Ther. 70:1996;1-37.
86. Toyota M., Ho C., Ahuja N., Jair K.W., Li Q., Ohe-Toyota M., Baylin S.B., Issa J.P. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59:1999;2307-2312.
87. Truss M., Chalepakis G., Pina B., Barettino D., Bruggemeier U., Kalff M., Slater E.P., Beato M. Transcriptional control by steroid hormones. J Steroid Biochem Mol Biol. 41:1992;241-248.
88. Ushijima T., Morimura K., Hosoya Y., Okonogi H., Tatematsu M., Sugimura T., Nagao M. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc Natl Acad Sci USA. 94:1997;2284-2289.
89. Van Broeckhoven C., Verheyen G. Chromosome 18 workshop. Psychiatr Genet. 8:1998;97-108.
90. Van Broeckhoven C., Verheyen G. Report on the Chromosome 18 workshop. Am J Med Genet (Neuropsychiatric Genetics). 88:1999;263-270.
91. Varela-Moreiras G., Ragel C., Perez de Miguelsanz J. Choline deficiency and methotrexate treatment induces marked but reversible changes in hepatic folate concentrations, serum homocysteine and DNA methylation rates in rats. Am Coll Nutr. 14:1995;480-485.
92. Williams J., Spurlock G., McGuffin P., Mallet J., Nothen M.M., Gill M., Aschauer H., Nylander P.O., Macciardi F., Owen M.J. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet. 347:1996;1294-1296.
93. Williams J., McGuffin P., Nothen M., Owen M.J. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet. 349:1997;1221.
94. Williams J., Spurlock G., Holmans P., Mant R., Murphy K., Jones L., Cardno A., Asherson P., Blackwood D., Muir W., Meszaros K., Aschauer H., Mallet J., Laurent C., Pekkarinen P., Seppala J., Stefanis C.N., Papadimitriou G.N., Macciardi F., Verga M., Pato C., Azevedo H., Crocq M.A., Gurling H., Kalsi G., Curtis D., McGuffin P., Owen M.J. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Molec Psychiat. 3:1998;141-149.
95. Xu G.-L., Bestor T.H. Cytosine methylation targetted to pre-determined sequences. Nature Genet. 17:1997;376-379.
96. Xu Y., Goodyer C.G., Deal C., Polychronakos C. Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem Biophys Res Commun. 197:1993;747-754.
97. Yang A.S., Jones P.A., Shibata A. The mutational burden of 5-methylcytosine. Russo V.E.A., Martienssen R.A., Riggs A.D. Epigenetic Mechanisms of Gene Regulation. 1996;77-94 New York, Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
98. Yokomori N., Moore R., Negishi M. Sexually dimorphic DNA demethylation in the promoter of the Slp (sex-limited protein) gene in mouse liver. Proc Natl Acad Sci USA. 92:1995;1302-1306.
99. Zirbel R.M., Mathieu U.R., Kurz A., Cremer T., Lichter P. Evidence for a nuclear compartment of transcription and splicing located at chromosome domain boundaries. Chromosome Res. 1:1993;93-106.